The cubic ternary complex receptor-occupancy model I. Model description

Journal of Theoretical Biology

Volumn 178, Issue 2, 1996, Pages 151-167

  Weiss, Jack M ^a   Morgan, Paul H ^b   Lutz, Michael W ^b   Kenakin, Terry P ^b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; LIGAND; RECEPTOR;

ARTICLE; COMPLEX FORMATION; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; STATISTICAL ANALYSIS;

EID: 0029935383     PISSN: 00225193     EISSN: None     Source Type: Journal    
DOI: 10.1006/jtbi.1996.0014     Document Type: Article

References (65)

1. ABRAMSON, S. N., MCGONIGLE, P. & MOLINOFF, P. B. (1987). Evaluation of models for analysis of radioligand binding data. Mol. Pharmacol. 31, 103-111.
2. AGRESTI, A. (1990). Categorical Data Analysis. New York: John Wiley & Sons.
3. ARIËNS, E. J. (1954). Affinity and intrinsic activity in the theory of competitive inhibition. Part I. Problems and theory. Arch. int. Pharmacodyn. Thér. 99, 32-49.
4. ARIËNS, E. J. (1964). Molecular Pharmacology: The Mode of Action of Biologically Active Compounds. New York: Academic Press.
5. BIRNBAUMER, L. G. (1990). G proteins in signal transduction. Annu. Rev. Pharmacol. Toxicol. 30, 675-705.
6. BIRNBAUMER, L. G., SWARTZ, T. L., ABRAMOWITZ, J., MINTZ, P. W. & IYENGAR, R. (1980). Transient and steady state kinetics of the interaction of guanyl nucleotides with the adenylyl cyclase system from rat liver plasma membranes. Interpretation in terms of a simple two-state model. J. Biol. Chem. 255, 3542-3551.
7. BIRNBAUMER, L. G., YATANI, A., VANDONGEN, A. M. J., GRAF, R., CODINA, J., OKABE, K., MATTERA, R. & BROWN, A. M. (1990). G protein coupling of receptors to ionic channels and other effector systems. In: G Proteins and Signal Transduction (Nathanson, N. M. & Harden, T. K., eds), pp. 169-183. New York: Rockefeller University Press.
8. BISHOP, Y. M. M., FEINBERG, S. E. & HOLLAND, P. W. (1975). Discrete Multivariate Analysis: Theory and Practice. Cambridge, MA: MIT Press.
9. BOEYNAEMS, J. M. & DUMONT, J. E. (1977). The two-step model of ligand-receptor interaction. Mol. Cell. Endocrinol. 7, 33-417.
10. BOURNE, H. R., SANDERS, D. A. & MCCORMICK. F. (1990). The GTPase superfamily: a conserved switch for diverse cell functions. Nature 348, 125-132.
11. CHANGEUX, J.-P., THIÉRY, J., TUNG, Y. & KITTEL, C. (1967). On the cooperativity of biological membranes. Proc. natl. Acad. Sci. USA 57, 335-341.
12. CLARK, A. J. (1933). The Mode of Action of Drugs on Cells. London: Edward Arnold.
13. CLARK, A. J. (1937). General Pharmacology. In: Heffner's Handbuch der Experimentellen Pharmakologie Erganzungswerk Band 4. Berlin: Springer-Verlag.
14. COLQUHOUN, D. (1973). The relationship between classical and cooperative models for drug action. In: A Symposium on Drug Receptors (H. P. Rang, ed), pp. 149-182. Baltimore: University Park Press.
15. COSTA, T., OGINO, Y., MUNSON, P. J., ONARAH, H. O. & RODBARD, D. (1992). Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. Mol. Pharmacol. 41, 549-560.
16. 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function. Proc. natl. Acad. Sci. USA 87, 2896-2900.
17. CUATRECASAS, P. (1974). Membrane receptors. Ann. Rev. Biochem. 43, 169-214.
18. DE LÉAN, A., STADEL, J. M. & LEFKOWITZ, R. J. (1980). A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled β-adrenergic receptor. J. Biol. Chem. 255, 7108-7117.
19. DEL CASTILLO, J. & KATZ, B. (1957). Interaction at end-plate receptors between different choline derivatives. Proc. R. Soc. London, B. 146, 369-381.
20. DOBSON, A. J. (1990). An Introduction to Generalized Linear Models. New York: Chapman & Hall.
21. EHLERT, F. J. (1985). The relationship between muscarinic receptor occupancy and adenylate cyclase inhibition in the rabbit myocardium. Mol. Pharmacol. 28, 410-421.
22. GADDUM, J. H. (1937). The quantitative effects of antagonistic drugs. J. Physiol., Lond. 89, 7P-9P.
23. GADDUM, J. H. (1957). Theories of drug antagonism. Pharmacol. Rev. 9, 211-218.
24. HEIDENREICH, K. A., WEILAND, G. A. & MOLINOFF, P. B. (1980). Characterization of radiolabeled agonist binding to β-adrenergic receptors in mammalian tissue. J. Cyclic Nucleotide Res. 6, 217-230.
25. HILL, A. Y. (1909). The mode of action of nicotine and curari, determined by the form of the contraction curve and the method of temperature coefficients. J. Physiol., Lond. 39, 361-373.
26. IYENGAR, R., ABRAMOWITZ, J., BORDELON-RISER, M. & BIRNBAUMER, L. (1980). Hormone receptor-mediated stimulation of adenylyl cyclase systems. Nucleotide effects and analysis in terms of a simple two-state model for the basic receptor-affected enzyme. J. Biol. Chem. 255, 3558-3564.
27. JACOBS, S. & CUATRECASAS, P. (1976). The mobile receptor hypothesis and "cooperativity" of hormone binding: applications to insulin. Biochim. Biophys. Acta 433, 482-495.
28. KARLIN, A. (1967). On the application of "a plausible model" of allosteric proteins to the receptor for acetylcholine. J. theor. Biol. 16, 306-320.
29. KATZ, B & THESLEFF, S. (1957). A study of the 'desensitization' produced by acetylcholine at the motor end-plate. J. Physiol., Lond. 138, 63-80.
30. KENAKIN, T. P. (1989). Challenges for receptor theory as a tool for drug and drug receptor classification. Trends Pharmacol. Sci. 10, 18-22.
31. KENAKIN, T. P. (1993). Pharmacologic Analysis of Drug-Receptor Interaction. New York: Raven Press.
32. KENAKIN, T. P. & MORGAN, P. H. (1989). Theoretical effects of single and multiple transducer receptor coupling proteins on estimates of the relative potency of agonists. Mol. Pharmacol. 35, 214-222.
33. KIRSCHNER, L. B. & STONE, W. E. (1951). Action of inhibitors at the myoneural junction. J. Gen. Physiol. 34, 821-834.
34. 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. J. Biol. Chem. 267, 1430-1433.
35. KLOTZ, I. M. (1986). Introduction to Biomolecular Energetics: Including Ligand-Receptor Interactions. Orlando, FL: Academic Press.
36. KNOKE, D. & BURKE, P. J. (1980). Log-linear Models. Beverly Hills, CA: Sage.
37. KOTZE, T. J. v. W. (1980). The log-linear model and its application to multi-way contingency tables. In: Topics in Applied Multivariate Analysis (Hawkins, D. M., ed), pp. 142-182. Cambridge: Cambridge University Press.
38. LANGLEY, J. N. (1878). On the physiology of the salivary secretion. Part II. On the mutual antagonism of atropin and pilocarpin, having especial reference to their relations in the submaxillary gland of the cat. J. Physiol., Lond. 1, 339-369.
39. LANGLEY, J. N. (1909). On the contraction of muscle, chiefly in relation to the presence of 'receptive' substances. Part IV. The effect of curari and of some other substances on the nicotine response of the sartorious and gastrocnemis muscles of the frog. J. Physiol., Lond. 39, 235-295.
40. LAUFFENBURGER, D. A. & LINDERMAN, J. J. (1993). Receptors: models for binding, trafficking, and signalling. New York: Oxford University Press.
41. LEE, T. W. T., SOLE, M. J. & WELLS, J. W. (1986). Assessment of a ternary model for the binding of agonists to neurohumoral receptors. Biochemistry 25, 7009-7020.
42. LEFF, P., DOUGALL, I. G., HARPER, D. H. & DAINTY, I. A. (1990). Errors in agonist affinity estimation: do they and should they occur in isolated tissue experiments? Trends Pharmacol. Sci. 11, 64-67.
43. LEFKOWITZ, R. J., COTECCHIA, S., SAMAMA, P. & COSTA, T. (1993). Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol. Sci. 14, 303-307.
44. MACKAY, D. (1987). Use of null equations, based on classical and ternary models of drug action, to classify receptors and receptor-effector systems even if some of the agonists and antagonists available have additional actions on the tissues. In: Perpectives on Receptor Classification (Black, J. W., Jenkinson, D. H. & Gerskowitch, V. P., eds), pp. 193-206. New York: Alan R. Liss.
45. MACKAY, D. (1988). Continuous variation of agonist affinity constants. Trends Pharmacol. Sci. 9, 156-157.
46. MACKAY, D. (1990). Agonist potency and apparent affinity: interpretation using classical and steady-state ternary-complex models. Trends Pharmacol. Sci. 11, 17-22.
47. MAYO, K. H., NUNEZ, M., BURKE, C., STARBUCK, C., LAUFFENBURGER, D. & SAVAGE, C. R., JR. (1989). Epidermal growth factor receptor binding is not a simple one-step process. J. Biol. Chem. 264, 17838-17844.
48. MINTON, A. P. & SOKOLOVSKY, M. (1990). A model for the interaction of muscarinic receptors, agonists, and two distinct effector substances. Biochemistry 29, 1586-1593.
49. MORGAN, P. H. (1993). Agonist action revisited. Trends Pharmacol. Sci. 14, 421-423.
50. 2 adrenergic receptors: evidence for a precoupled receptor-guanine nucleotide protein complex. Biochemistry 27, 2374-2384.
51. NIHOUL, J. C. J. (1994). Do not use a simple model when a complex one will do. Journal of Marine Systems 5, 401-410.
52. PARMA, J., DUPREZ, L., VAN SANDE, J., COCHAUX, P., GERVY, C., MOCKEL, J., DUMONT, J. & VASSART, G. (1993). Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365, 649-651.
53. PEPPERL, D. J. & REGAN, J. W. (1994). Adrenergic receptors. In: G Protein Coupled Receptors (Peroutka, S. J., ed), pp. 45-78. Boca Raton: CRC Press.
54. PIELOU, E. C. (1974). Population and Community Ecology: Principles and Methods. New York: Gordon and Breach.
55. PODLESKI, T. R. & CHANGEUX, J.-P. (1970). On the excitability and cooperativity of the electroplax membrane. In: Fundamental Concepts in Drug-Receptor Interaction (Danielli, J. F., Moran, J. F. & Triggle, D. J., eds), pp. 93-119. New York: Academic Press.
56. 125I-glucagon. J. Biol. Chem. 246, 1872-1876.
57. Ross, E. M., MAGUIRE, M. E., STURGILL, T. W., BILTONEN, R. L. & GILMAN, A. G. (1977). Relationship between the β-adrenergic receptor and adenylate cyclase. Studies of ligand binding and enzyme activity in purified membranes of S49 lymphoma cells. J. Biol. Chem. 252, 5761-5775.
58. Ross, E. M. (1989). Signal sorting and amplification through G protein-coupled receptors. Neuron 3, 141-152.
59. 2-adrenergic receptor. Extending the ternary complex model. J. Biol. Chem. 268, 4625-4636.
60. SHENKER, A., LAUE, L., KOSUGI, S., MERENDINO, J. J., JR., MINEGISHI, T. & CUTLER, G. B., JR. (1993). A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 365, 652-654.
61. STEPHENSON, R. P. (1956). A modification of receptor theory. Brit. J. Pharmacol. 11, 379-393.
62. STERNWEIS, P. C., NORTHUP, J. K., SMIGEL, M. D. & GILMAN, A. G. (1981). The regulatory component of adenylate cyclase: purification and properties J. Biol. Chem. 256, 11517-11526.
63. THRON, C. D. (1973). On the analysis of pharmacological experiments in terms of an allosteric receptor model. Mol. Pharmacol. 9, 1-9.
64. 2-dopamine receptor of the anterior pituitary gland. Mol. Pharmacol. 26, 214-227.
65. WYMAN, J. (1975). The turning wheel: A study in steady states. Proc. natl. Acad. Sci. USA 72, 3983-3987.